NCT07383818 2026-02-03Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)First Affiliated Hospital of Zhejiang UniversityPhase 2 Recruiting111 enrolled